HYPR stock forecast
Our latest prediction for Hyperfine Inc's stock price was made on the Dec. 5, 2022 when the stock price was at 0.73$.
In the short term (2weeks), HYPR's stock price should underperform the market by -1.80%. During that period the price should oscillate between -8.86% and +9.00%.
In the medium term (3months), HYPR's stock price should underperform the market by -7.63%. During that period the price should oscillate between -31.33% and +23.65%.Get email alerts
Create a solid portfolio with HYPR
About Hyperfine Inc
Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the world’s first FDA-cleared portable MRI system. Hyperfine designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose, and treat patients in various clinical settings. Swoop can be wheeled directly to the patient’s bedside, plugged into a standard electrical wall outlet, and controlled by a tablet. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making capabilities in emergency departments (ED), operating rooms (OR) outside the sterile field, and intensive care units (ICU), among others.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of None$ per share.
The book value per share is None$
Three months stock forecastDec. 5, 2022
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|